Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Durvalumab and Tremelimumab in Combination With Y-90 SIRT for Intermediate Stage HCC

Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest · 2020
ClinicalTrials.gov · Datasets · License: Public Domain · 2020
Open Source ↗
hcchepatocellularcarcinoma
hepatocellular carcinoma non-resectable, hcc, hepatocellular carcinoma, intermediate stage hcc, sirt, durvalumab, tremelimumab, tace, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 860170
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.